The global pacemakers market is expected to reach US$ 10,908.0 Mn in 2027 from US$ 5,485.4 in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027. Driving factors such as, increasing burden of cardiovascular diseases, neurological disorders & hearing disorders, increasing technological advancements, and large pool of geriatric population. Additionally, the future trends such as product innovations is likely to increase the growth of the pacemakers market in the forecasted period. In developed and maturing markets, major pacemakers companies are seeking for market growth by developing novel products.Growing demand for high quality healthcare services and products poses a need for rapid product innovations.
Hence, over the years, companies are developing new products in order to meet the rising healthcare needs.For instance, in May 2018, LivaNova initiated a clinical study of its Vitaria neuromodulation implant for treating heart failure.
The Vitaria System includes an implantable pulse generator, vagus nerve lead, programming system and patient kit that delivers autonomic regulation therapy that promotes improvements in heart function.Also, the Medtronic in May 2018, announced a clinical study for its newly developed Micra Transcatheter Pacing System with a novel mechanical sensor.
The novel mechanical sensor allows patients to benefit from a miniaturized leadless pacemaker. Furthermore, researchers are studying the use of implantable devices for visual loss and developing innovative retinal implants for people with retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD). Thus, the above advancements and owing to growing product innovations is expected to fuel the future growth of this market. Global pacemakers market was segmented by product type, technology, and end user.The product type segment was further divided as implantable robots and external pacemakers.
On the basis of technology, the market is segmented into the single chambered, dual chambered and bi-ventricular.Based on the end user, the pacemakers market is segmented into hospitals, ambulatory surgical centers, and others.
The hospitals segment held a major market share among the end user segment owing to the growing increasing number of patient admissions in these facilities across the globe. Some of the major primary and secondary sources included in the report for the pacemakers market are Centers for Disease control and Prevention (CDC), China Food and Drug Administration (CFDA), Council of Scientific and Industrial Research (CSIR), European Medicines Agency (EMA), Japan Society for the Promotion of Science (JSPS), and others.
Our reports have been used by over 10K customers, including:
The microplate reader market was valued at US$ 534.5 million in 2019 and is projected to reach US$ 704.4 million by 2027; it is expected to grow at a CAGR of 3.6% during 2020–2027. The market is attributed to increasing research and development in the pharmaceuticals industry, and escalating incidence of infectious diseases. However, high...
184 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Acetic Anhydride has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
The nucleotides market is expected to grow at a CAGR of over 8% during the forecast period. The major factor driving the market studied is the growing demand for nucleotides from pharmaceuticals and Increased Demand due to the COVID-19 Outbreak. On the flip side, the high manufacturing cost of nucleotides are hindering the growth of the market. -...
275 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4.3% during 2020–2027. The growth of the market is mainly attributed to the increasing prevalence of diabetes and growing geriatric population. However, side effects of gastroparesis...
The water soluble polymer market is expected to register a CAGR of over 4% during the forecast period. The factors driving the growth of the market studied are the growing shale gas industry in North America and the water treatment industry in the Asia-Pacific region. - On the flip side, other than the impact of COVID-19 pandemic on...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
The chromatography resin market size is estimated to be USD 2.2 billion in 2020 and is projected to reach USD 3.3 billion by 2025, at a CAGR of 8.2% between 2020 and 2025. Factors such as increasing demand for therapeutic antibodies, public-private investment in pharmaceutical & life science research, and rising concern for food safety will...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.